V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10459942 | 10034865 | 1.66 | 71.4 | Palliative (P) | 2022-03-19 | 2022-03-19 | CAPECITABINE + OXALIPLATIN | 99 | null | CAPECITABINE | 101259346 |
| 10459954 | 10034866 | 1.73 | 84 | Palliative (P) | 2017-03-29 | 2017-06-29 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE | 100308566 |
| 10459985 | 10034867 | 1.68 | 58.5 | Neo-adjuvant (N) | 2016-12-20 | 2016-12-20 | IBRUTINIB | 02 | Y | IBRUTINIB | 101797018 |
| 10459986 | 10034868 | 1.7 | 69.7 | Curative (C) | 2016-03-19 | 2016-03-19 | IBRUTINIB | 02 | N | IBRUTINIB | 100328303 |
| 10460030 | 10034869 | 1.67 | 55.6 | Palliative (P) | null | 2019-12-16 | IBRUTINIB | 02 | N | IBRUTINIB | 100411511 |
| 10460056 | 10034870 | 1.68 | 80.7 | Palliative (P) | 2016-04-19 | 2016-04-19 | Rituximab | 02 | N | RITUXIMAB | 101286513 |
| 10460061 | 10034871 | null | 86.1 | null | 2021-05-25 | 2021-06-03 | Capecitabine | 02 | null | CAPECITABINE | 100597922 |
| 10460068 | 10034872 | 1.64 | 97 | 03 | 2017-08-28 | 2017-09-05 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100922312 |
| 10460082 | 10034873 | 1.73 | 73.8 | null | 2020-08-07 | 2020-09-08 | Capecitabine + Oxaliplatin 21day | 02 | null | DOCETAXEL | 101216088 |
| 10460105 | 10034874 | 1.7 | 86.9 | Palliative (P) | 2016-05-13 | 2016-05-15 | Rituximab | 02 | N | RITUXIMAB | 100310934 |
| 10460110 | 10034875 | 1.64 | 68.1 | null | 2022-05-01 | 2022-05-08 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE | 100986740 |
| 10460112 | 10034876 | 1.7 | 88 | null | 2021-07-15 | 2021-07-23 | IBRUTINIB | 02 | null | IBRUTINIB | 101016363 |
| 10460119 | 10034877 | 1.75 | 82 | Adjuvant (A) | 2020-02-10 | 2020-02-20 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101669670 |
| 10460120 | 10034878 | 0 | 72.3 | Adjuvant (A) | 2019-04-05 | 2019-04-05 | CAPECITABINE + OXALIPLATIN | 02 | N | IBRUTINIB | 100248162 |
| 10460122 | 10034879 | 1.52 | 119 | 03 | 2016-04-08 | 2016-04-18 | Capecitabine + Oxaliplatin 21day | N | N | IBRUTINIB | 100544973 |
| 10460146 | 10034880 | 1.72 | 60.3 | 03 | 2018-08-26 | 2018-09-13 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101151674 |
| 10460147 | 10034881 | 1.8 | 89 | Adjuvant (A) | 2020-01-12 | 2020-01-26 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101742369 |
| 10460163 | 10034882 | 1.73 | 99.95 | 03 | 2019-09-20 | 2019-09-20 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101809791 |
| 10460166 | 10034883 | 1.72 | 59 | 03 | null | 2020-01-04 | Capecitabine | 02 | N | CAPECITABINE | 101588527 |
| 10460173 | 10034884 | 0 | 70.7 | 03 | 2014-04-07 | 2014-04-08 | IBRUTINIB | 02 | N | IBRUTINIB | 101304585 |
| 10460205 | 10034885 | 1.86 | 69.15 | Palliative (P) | 2019-09-10 | 2019-09-21 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100140700 |
| 10460207 | 10034886 | 1.77 | 92.2 | 03 | 2019-11-10 | 2019-11-24 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100620442 |
| 10460208 | 10034887 | 1.78 | 100 | Adjuvant (A) | 2020-02-29 | 2020-02-29 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100014384 |
| 10460215 | 10034888 | 1.76 | 58.2 | null | 2021-06-12 | 2021-06-12 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100866121 |
| 10460262 | 10034890 | 1.62 | 0 | Palliative (P) | 2015-05-16 | 2015-05-30 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100156368 |
| 10460273 | 10034891 | 1.67 | 80.2 | null | 2021-04-05 | 2021-04-19 | Rituximab | 02 | null | RITUXIMAB | 100450724 |
| 10460293 | 10034892 | 1.79 | 72 | Palliative (P) | 2019-08-12 | 2019-08-19 | Capecitabine | 02 | N | CAPECITABINE | 100341936 |
| 10460311 | 10034893 | null | 97.6 | Palliative (P) | null | 2015-11-22 | Capecitabine + Oxaliplatin 21day | N | N | PEMBROLIZUMAB | 100071759 |
| 10460356 | 10034894 | 1.74 | 76 | Curative (C) | 2017-09-27 | 2017-09-29 | IBRUTINIB | 02 | N | IBRUTINIB | 101269493 |
| 10460374 | 10034895 | 1.77 | 89.6 | null | 2018-08-19 | 2018-09-01 | Capecitabine | 02 | null | CAPECITABINE | 100488751 |
| 10460407 | 10034896 | 1.89 | 65.5 | null | 2021-05-25 | 2021-05-25 | Rituximab | 02 | null | RITUXIMAB | 100546940 |
| 10460412 | 10034897 | 1.72 | 76 | null | 2022-01-12 | 2022-01-22 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE | 101301221 |
| 10460425 | 10034898 | 1.65 | 63 | Palliative (P) | 2019-03-30 | 2019-04-06 | Capecitabine | 02 | N | CAPECITABINE | 100152824 |
| 10460434 | 10034899 | 1.79 | 66.4 | Palliative (P) | 2019-12-24 | 2020-01-14 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100014860 |
| 10460452 | 10034900 | 1.68 | null | Palliative (P) | 2018-10-25 | 2018-11-07 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | RITUXIMAB | 100877098 |
| 10460454 | 10034901 | 0.02 | 76 | Neo-adjuvant (N) | 2019-05-20 | 2019-05-20 | CAPECITABINE + OXALIPLATIN | 02 | null | IBRUTINIB | 100897068 |
| 10460476 | 10034902 | 1.66 | 73.6 | null | 2019-04-27 | 2019-05-05 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101688663 |
| 10460505 | 10034903 | 1.72 | 101 | Adjuvant (A) | 2018-04-25 | 2018-04-25 | Capecitabine | N | N | CAPECITABINE | 100843512 |
| 10460513 | 10034904 | 1.7 | 70 | Palliative (P) | 2020-08-23 | 2020-08-27 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101002370 |
| 10460517 | 10034905 | 1.63 | 80 | Neo-adjuvant (N) | 2020-03-20 | 2020-03-20 | Capecitabine | 02 | N | CAPECITABINE | 100924409 |
| 10460525 | 10034906 | 1.67 | 66.3 | Palliative (P) | 2017-10-21 | 2017-11-16 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 101357264 |
| 10460533 | 10034907 | 1.51 | 70.6 | null | 2020-12-13 | 2020-12-15 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100690744 |
| 10460538 | 10034908 | 1.9 | 86.4 | Curative (C) | 2016-03-22 | 2016-04-02 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 100559302 |
| 10460539 | 10034909 | 1.53 | 95.8 | Adjuvant (A) | 2016-10-13 | 2016-10-16 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101732772 |
| 10460558 | 10034910 | 1.82 | 97 | Palliative (P) | 2020-03-10 | 2020-03-10 | Capecitabine | 02 | N | CAPECITABINE | 101086509 |
| 10460579 | 10034911 | 1.59 | 76 | 03 | 2020-02-16 | 2020-02-19 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101539191 |
| 10460584 | 10034912 | null | 76.95 | Adjuvant (A) | 2019-07-18 | 2019-07-21 | IBRUTINIB | 02 | Y | IBRUTINIB | 101457639 |
| 10460638 | 10034913 | 1.58 | 78 | Not known (9) | 2015-08-25 | 2015-09-13 | CAPECITABINE + OXALIPLATIN | 02 | N | IBRUTINIB | 100531038 |
| 10460645 | 10034914 | 1.74 | 80.4 | Palliative (P) | 2017-03-01 | 2017-03-01 | PEMBROLIZUMAB | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101484526 |
| 10460672 | 10034915 | 1.84 | 97 | null | 2022-01-01 | 2022-01-01 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101191965 |